Compare · CNMD vs ITGR
CNMD vs ITGR
Side-by-side comparison of CONMED Corporation (CNMD) and Integer Holdings Corporation (ITGR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CNMD and ITGR operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- ITGR is the larger of the two at $3.24B, about 2.5x CNMD ($1.30B).
- Over the past year, CNMD is down 9.3% and ITGR is down 15.3% - CNMD leads by 5.9 points.
- CNMD has been more active in the news (9 items in the past 4 weeks vs 6 for ITGR).
- ITGR has more recent analyst coverage (23 ratings vs 16 for CNMD).
- Company
- CONMED Corporation
- Integer Holdings Corporation
- Price
- $43.21-4.01%
- $95.31-4.40%
- Market cap
- $1.30B
- $3.24B
- 1M return
- +25.25%
- +4.58%
- 1Y return
- -9.34%
- -15.28%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NYSE
- NYSE
- IPO
- 1987
- News (4w)
- 9
- 6
- Recent ratings
- 16
- 23
CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Integer Holdings Corporation
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and management systems, charging and docking stations, and power supplies for the energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Latest CNMD
- SEC Form 4 filed by Executive Vice President & CFO Gallagher John E
- New insider Gallagher John E claimed no ownership of stock in the company (SEC Form 3)
- BMO Capital Markets initiated coverage on CONMED with a new price target
- SEC Form 4 filed by Director Martin Celine Christine
- SEC Form 4 filed by Director Mirviss Jeffrey B.
- New insider Mirviss Jeffrey B. claimed no ownership of stock in the company (SEC Form 3)
- New insider Martin Celine Christine claimed no ownership of stock in the company (SEC Form 3)
- CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026
- CONMED downgraded by BofA Securities with a new price target
- CONMED Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure
Latest ITGR
- SEC Form 3 filed by new insider Metcalf Milo Stephen Ii
- SEC Form 4 filed by US - EVP, Operations Metcalf Milo Stephen Ii
- Integer Announces Conference Call to Discuss Second Quarter 2026 Results
- Chief Human Resources Officer Thor Kirk K converted options into 6,120 shares and covered exercise/tax liability with 2,409 shares, increasing direct ownership by 11% to 38,693 units (SEC Form 4)
- SEC Form 4 filed by President, Glob Ops & Manu Tec Harris John A
- Integer Holdings Corporation filed SEC Form 8-K: Leadership Update
- Integer to Participate in Truist Securities 2026 MedTech Conference on June 16
- Director Maxwell Martin C was granted 1,967 shares, increasing direct ownership by 9% to 25,106 units (SEC Form 4)
- SEC Form 4 filed by Director Hinrichs James F.
- Director Coyle Michael J was granted 1,967 shares, increasing direct ownership by 145% to 3,322 units (SEC Form 4)